Follow Us

Drug Approved for Inoperable Melanoma

Keytruda (pembrolizumab) was finally approved for the treatment of inoperable malignant melanoma. Testing was never completed as it performed so well in the early clinical trials.

About the Author
Is an Ivy-League trained physician and surgeon who is a board-certified Dermatologist & Mohs' Surgeon. Aside from having training in Internal Medicine and Dermatology, Dr. Bader completed a fully accredited fellowship in Cosmetic Surgery under the auspices of the American Academy of Cosmetic Surgery. He moved to South Florida in June 1999. Shortly thereafter, he formed R.S.B. Dermatology in Deerfield Beach, FL.